PHARMA
Otsuka Acquires Leukemia Drug Dacogen® From Eisai
Otsuka Pharmaceutical acquires two drugs, Dacogen® and E7727, from Eisai Co. to enhance their leukemia drug portfolio.
AstraZeneca, Shenzhen Uni To Study Chronic Kidney Disease
AstraZeneca and Shenzhen University Health Science Center will conduct pre-clinical research on chronic kidney disease, a large and growing unmet medical need in China.
Takeda Receives NDA Approval For Gastric Ulcer And Hypertension Drugs
Takeda's two new fixed dose combination drugs, TAKELDA® and Zacras®, receive approval from the Japanese Ministry of Health, Labor and Welfare.
Astellas, Daiichi Sankyo To Share 400,000 Drug Compounds
Two of Japan's largest pharmaceutical firms will share their drug libraries, making 400,000 compounds available for high throughput sequencing.
Sanofi Pasteur, SK Chemicals To Co-Develop Pneumococcal Vaccine
Vaccine-maker Sanofi Pasteur will invest US$23 million in South Korea's SK Chemicals for the development of pneumococcal conjugate vaccine.
Viva Biotech And HQL Pharmaceuticals Form Alliance
The alliance will combine Viva Biotech's expertise in fragment and structure based drug discovery and HQL Pharmaceutical's computational technology.
iKang Launches US$150 Million IPO On NASDAQ
The initial public offering is expected to raise US$150 million for expansion through acquisitions and the building of new medical centers.
Shanxi Taxus, Cardium Therapeutics Enter Partnership
China's Shanxi Taxus' investment in US firm Cardium Therapeutics for the development of two new drugs will also give both companies access to each others' home markets.
Biostar Partners Shaanxi University Of Chinese Medicine
Biostar pharmaceuticals and Shaanxi University of Chinese Medicine aim to develop oleanic acid into a liver cancer drug.
